Linvoseltamab

Linvoseltamab, also known by its brand name Lynozyfic, is a medication for people with multiple myeloma, particularly when other treatments haven't worked or the cancer has returned. This treatment is a type of immunotherapy, meaning it helps your own immune system find and remove myeloma cancer cells. It works by bringing specific immune cells in your body directly to the cancer cells. Linvoseltamab is an "off-the-shelf" therapy, which means it's ready to use and doesn't need to be custom-made for each person. Here, you can find information on how this treatment works, what to expect during administration, and how it may impact your treatment schedule if it is effective.